Amylyx Pharmaceuticals, Inc. ($AMLX)
Filing Information
| Accession Number | 0001193125-26-098439 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 9, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
186,650
Total Value
$0.00
P&L
+inf% (+$2,577,636.50)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Mar 5, 2026 | Grant/Award | 74,660 | $0.00 | $0.00 | 209,090 | Direct | โ | View Details | |
Chief Legal Officer | Stock Option (Right to Buy) | Derivative | Mar 5, 2026 | Grant/Award | 111,990 | $0.00 | $0.00 | 111,990 | Direct | โ | View Details |